228 related articles for article (PubMed ID: 31226865)
1. Preparation, Optimization, and In Vivo Evaluation of Nanoparticle-Based Formulation for Pulmonary Delivery of Anticancer Drug.
Chishti N; Jagwani S; Dhamecha D; Jalalpure S; Dehghan MH
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31226865
[No Abstract] [Full Text] [Related]
2. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
4. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
[TBL] [Abstract][Full Text] [Related]
5. Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells.
Conte C; Monteiro PF; Gurnani P; Stolnik S; Ungaro F; Quaglia F; Clarke P; Grabowska A; Kavallaris M; Alexander C
Nanoscale; 2021 Jul; 13(26):11414-11426. PubMed ID: 34160534
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation.
Hu X; Yang F; Liao Y; Li L; Zhao G; Zhang L
Int J Nanomedicine; 2020; 15():5361-5376. PubMed ID: 32801694
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
9. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
11. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation
Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y
Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation.
Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y
Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488
[TBL] [Abstract][Full Text] [Related]
14. Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
Zhu X; Kong Y; Liu Q; Lu Y; Xing H; Lu X; Yang Y; Xu J; Li N; Zhao D; Chen X; Lu Y
Pulm Pharmacol Ther; 2019 Apr; 55():50-61. PubMed ID: 30738974
[TBL] [Abstract][Full Text] [Related]
15. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.
Sanna V; Roggio AM; Posadino AM; Cossu A; Marceddu S; Mariani A; Alzari V; Uzzau S; Pintus G; Sechi M
Nanoscale Res Lett; 2011 Mar; 6(1):260. PubMed ID: 21711774
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
17. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma.
Xu L; Wu S; Zhou X
J Biomater Appl; 2018 Jul; 33(1):72-81. PubMed ID: 29699442
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]